4-amino-2-butoxy-8-(3-(1-pyrrolidinylmethyl)benzyl)-7,8-dihydro-6(5H)-pteridinone,
GS-9620,
vesatolimod,
GS-9620,
1228585-88-3,
Vesatolimod,
GS9620,
UNII-O8M467C50G,
GS 9620,
CHEMBL2424780,
O8M467C50G,
8-(3-(pyrrolidin-1-ylmethyl)benzyl)-4-amino-2-butoxy-7,8-dihydropteridin-6(5H)-one,
4-Amino-2-butoxy-8-(3-(pyrrolidin-1-ylmethyl)benzyl)-7,8-dihydropteridin-6(5H)-one,
4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one,
4-azanyl-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one,
Vesatolimod [INN],
Vesatolimod (USAN/INN),
Vesatolimod [USAN:INN],
SCHEMBL10083191,
DTXSID40153741,
VFOKSTCIRGDTBR-UHFFFAOYSA-N,
AOB87720,
BCP08305,
EX-A2065,
BDBM50440284,
MFCD25372045,
s7221,
ZINC95616590,
AKOS025290740,
CS-1352,
DB12687,
SB16757,
6(5H)-Pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-((3-(1-pyrrolidinylmethyl)phenyl)methyl)-,
NCGC00390283-03,
AC-30275,
AK170456,
BC600412,
HY-15601,
FT-0721305,
D11003,
W-6059,
4-Amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-6(5H)-pteridinone,
9JR,
D08JWC,
ACN-038540,
A3444,
A13251,
6(5h)-pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl]-,
4-Amino-2-butoxy-8-[3-(pyrrolidin-1-ylmethyl)benzyl]-7,8-dihydropteridin-6(5H)-one,
6(5H)-Pteridinone, 4-amino-2-butoxy-7,8-dihydro-8-[[3-(1-pyrrolidinylmethyl)phenyl]methyl],